Clinical Research News Podcast Discusses Solara and LiveSLR

November 25, 2021

The impact of Cytel’s Solara and LiveSLR technologies on the relationship between forecasting and evidence technology is examined on the podcast Clinical Research News. Anna Forsythe, Vice President of Value and Access at Cytel’s Purple Squirrel Economics, discusses how differing evidence thresholds between regulatory bodies and market-access gatekeepers confounds manufacturers’ attempts to clear the requirements of both.

According to Cytel, they are “reshaping this relationship with the use of two revolutionary technologies; Solara and LiveSLR, together these platforms can be used to ensure the correct and sufficient forecasting is performed and sufficient evidence is generated to increase a therapy’s probability of success”.

Sign up for the podcast by clicking here.

(Source: Cytel, November 23rd, 2021)

Share This Story!